help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, J. C.
Right arrow Articles by Hodson, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, J. C.
Right arrow Articles by Hodson, W. A.

Am. J. Respir. Crit. Care Med., Vol 150, No. 2, 08 1994, 534-539.

Reduction in lung injury after combined surfactant and high-frequency ventilation

JC Jackson, WE Truog, TA Standaert, JH Murphy, SE Juul, EY Chi, J Hildebrandt and WA Hodson
Department of Pediatrics, Pathology, University of Washington, Seattle 98195.

Previous studies demonstrated that high-frequency oscillatory ventilation (HFOV) begun at birth limits the development of alveolar proteinaceous edema in premature monkeys at risk for hyaline membrane disease (HMD). We hypothesized that exogenous surfactant combined with HFOV would lead to even further reductions in edema. Twenty Macaca nemestrina monkeys were delivered at 134 d gestation (term = 168 d) and treated with either HFOV or conventional mechanical ventilation (CMV) from the first breath; modified bovine surfactant (Survanta [beractant]) was introduced into the trachea over the first few minutes of life. These animals were compared with 20 animals treated with either CMV or HFOV but without surfactant. At 6 h the lung was rapidly frozen in situ during inflation for determination of the volume fraction of alveolar edema. The combined use of surfactant and HFOV from the first breath reduced alveolar proteinaceous edema (3 +/- 1%; mean +/- SEM) from that seen with CMV alone (27 +/- 3%, p < 0.0001), CMV after surfactant (21 +/- 3%, p < 0.0001), and HFOV alone (13 +/- 3%, p < 0.015). We conclude that the use of surfactant with HFOV after premature birth is superior to either surfactant or HFOV alone in reducing lung injury during the first few hours of life. We speculate that this reduction in lung injury may reduce the incidence or severity of bronchopulmonary dysplasia.


This article has been cited by other articles:


Home page
PediatricsHome page
P. Truffert, J. Paris-Llado, B. Escande, J.-F. Magny, G. Cambonie, E. Saliba, G. Thiriez, V. Zupan-Simunek, T. Blanc, J.-C. Roze, et al.
Neuromotor Outcome at 2 Years of Very Preterm Infants Who Were Treated With High-Frequency Oscillatory Ventilation or Conventional Ventilation for Neonatal Respiratory Distress Syndrome
Pediatrics, April 1, 2007; 119(4): e860 - e865.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. H. Habib, K. H. Pyon, and S. E. Courtney
Optimal High-Frequency Oscillatory Ventilation Settings by Nonlinear Lung Mechanics Analysis
Am. J. Respir. Crit. Care Med., October 1, 2002; 166(7): 950 - 953.
[Abstract] [Full Text]


Home page
NEJMHome page
S. E. Courtney, D. J. Durand, J. M. Asselin, M. L. Hudak, J. L. Aschner, C. T. Shoemaker, and the Neonatal Ventilation Study Group
High-Frequency Oscillatory Ventilation versus Conventional Mechanical Ventilation for Very-Low-Birth-Weight Infants
N. Engl. J. Med., August 29, 2002; 347(9): 643 - 652.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. R. Gerstmann, K. Wood, A. Miller, M. Steffen, B. Ogden, R. A. Stoddard, and S. D. Minton
Childhood Outcome After Early High-Frequency Oscillatory Ventilation for Neonatal Respiratory Distress Syndrome
Pediatrics, September 1, 2001; 108(3): 617 - 623.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. P. Shenai;, P. Rimensberger;, U. Thome, F. Pohlandt;, and P. Rimensberger
High-Frequency Oscillation and Chronic Lung Disease in Very Low Birth Weight Infants
Pediatrics, July 1, 2001; 108(1): 212 - 214.
[Full Text]


Home page
PediatricsHome page
G. Moriette, J. Paris-Llado, H. Walti, B. Escande, J.-F. Magny, G. Cambonie, G. Thiriez, S. Cantagrel, T. Lacaze-Masmonteil, L. Storme, et al.
Prospective Randomized Multicenter Comparison of High-Frequency Oscillatory Ventilation and Conventional Ventilation in Preterm Infants of Less Than 30 Weeks With Respiratory Distress Syndrome
Pediatrics, February 1, 2001; 107(2): 363 - 372.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. A. YODER, T. SILER-KHODR, V. T. WINTER, and J. J. COALSON
High-frequency Oscillatory Ventilation . Effects on Lung Function, Mechanics, and Airway Cytokines in the Immature Baboon Model for Neonatal Chronic Lung Disease
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1867 - 1876.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
K. Weber, S. E. Courtney, K. H. Pyon, G. Y. Chang, P. B. Pandit, and R. H. Habib
Detecting lung overdistention in newborns treated with high-frequency oscillatory ventilation
J Appl Physiol, July 1, 2000; 89(1): 364 - 372.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
P. C. Rimensberger, M. Beghetti, S. Hanquinet, and M. Berner
First Intention High-Frequency Oscillation With Early Lung Volume Optimization Improves Pulmonary Outcome in Very Low Birth Weight Infants With Respiratory Distress Syndrome
Pediatrics, June 1, 2000; 105(6): 1202 - 1208.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
F. Cools and M. Offringa
Meta-analysis of elective high frequency ventilation in preterm infants with respiratory distress syndrome
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1999; 80(1): 15F - 20.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. IKEGAMI, K. WADA, G. A. EMERSON, C. M. REBELLO, R. E. HERNANDEZ, and A. H. JOBE
Effects of Ventilation Style on Surfactant Metabolism and Treatment Response in Preterm Lambs
Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 638 - 644.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1994 American Thoracic Society